NovaBay Pharmaceuticals Inc Working Capital to Net Assets Ratio
NovaBay Pharmaceuticals Inc working capital to net assets ratio. NovaBay Pharmaceuticals Inc (NBY) has a Working Capital to Net Assets ratio of -33.0% as of December 2025. Working capital of $7.53 Million (current assets of $8.68 Million minus current liabilities of $1.14 Million) is measured against net assets of $-22.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check NovaBay Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of NovaBay Pharmaceuticals Inc (2005–2025)
Working capital to net assets ratio of NovaBay Pharmaceuticals Inc from 2005 to 2025. This chart shows how NovaBay Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the ratio stands at -33.0%, reflecting working capital of $7.53 Million against net assets of $-22.83 Million USD. See NBY days of operational coverage to measure how many days the company can operate on defensive assets alone.
NovaBay Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2005–2025)
NovaBay Pharmaceuticals Inc working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for NovaBay Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of NovaBay Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -33.0% | $7.53 Million | $-22.83 Million | $8.68 Million | $1.14 Million | ▼ -736.9 pp |
| 2024 | 703.9% | $-908.00K | $-129.00K | $1.94 Million | $2.84 Million | ▲ +617.1 pp |
| 2023 | 86.8% | $2.88 Million | $3.31 Million | $7.15 Million | $4.28 Million | ▲ +19.7 pp |
| 2022 | 67.0% | $7.08 Million | $10.55 Million | $11.33 Million | $4.26 Million | ▼ -28.6 pp |
| 2021 | 95.6% | $9.73 Million | $10.17 Million | $13.17 Million | $3.44 Million | ▲ +3.0 pp |
| 2020 | 92.6% | $11.41 Million | $12.32 Million | $14.24 Million | $2.83 Million | ▼ -287.0 pp |
| 2019 | 379.7% | $3.69 Million | $973.00K | $9.38 Million | $5.69 Million | ▲ +283.5 pp |
| 2018 | 96.1% | $4.76 Million | $4.95 Million | $8.61 Million | $3.85 Million | ▼ -58.7 pp |
| 2017 | 154.8% | $4.02 Million | $2.59 Million | $8.99 Million | $4.98 Million | ▲ +11.9 pp |
| 2016 | 142.9% | $10.15 Million | $7.10 Million | $14.47 Million | $4.32 Million | ▲ +140.8 pp |
| 2015 | 2.1% | $-106.00K | $-5.10 Million | $4.53 Million | $4.63 Million | ▼ -193.1 pp |
| 2014 | 195.2% | $3.61 Million | $1.85 Million | $6.95 Million | $3.35 Million | ▲ +64.1 pp |
| 2013 | 131.1% | $11.16 Million | $8.52 Million | $14.79 Million | $3.63 Million | ▲ +23.6 pp |
| 2012 | 107.5% | $15.11 Million | $14.05 Million | $18.28 Million | $3.17 Million | ▼ -17.9 pp |
| 2011 | 125.4% | $11.72 Million | $9.34 Million | $14.56 Million | $2.84 Million | ▲ +20.3 pp |
| 2010 | 105.2% | $11.03 Million | $10.49 Million | $13.75 Million | $2.72 Million | ▲ +18.5 pp |
| 2009 | 86.7% | $11.57 Million | $13.35 Million | $15.61 Million | $4.04 Million | ▼ -22.7 pp |
| 2008 | 109.4% | $8.03 Million | $7.34 Million | $12.51 Million | $4.48 Million | ▼ -17.7 pp |
| 2007 | 127.1% | $18.19 Million | $14.32 Million | $22.77 Million | $4.58 Million | ▼ -310.1 pp |
| 2006 | 437.2% | $7.93 Million | $1.81 Million | $11.31 Million | $3.39 Million | ▲ +345.4 pp |
| 2005 | 91.8% | $2.98 Million | $3.25 Million | $3.29 Million | $310.00K | — |